LeonaBio, Inc. Other Noncash Expense
LeonaBio, Inc. (LONA) reported Other Noncash Expense of $1.40 million for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-28.
Discontinued › Cash Flow › Operating Activities
us-gaap:OtherNoncashExpense · last filed 2022-03-28
- LeonaBio, Inc. other noncash expense for the quarter ending 2020-12-31 was -$2.00K.
- LeonaBio, Inc. other noncash expense for the quarter ending 2020-09-30 was $1.09M.
- LeonaBio, Inc. other noncash expense for fiscal 2020 was $1.40M.
| Period end | Other Noncash Expense 3 month | Other Noncash Expense 6 month | Other Noncash Expense 9 month | Other Noncash Expense 12 month |
|---|---|---|---|---|
| 2020-12-31 | -$2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $1.09M derived: sum of 2 quarters · filed 2022-03-28 | $1.40M 10-K · filed 2022-03-28 | |
| 2020-09-30 | $1.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $1.40M 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | $310.00K 10-Q · filed 2021-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |